Regeneron's first-quarter results missed Wall Street estimates on Tuesday due to stiff competition for its blockbuster drug ...

After consecutive setbacks at the FDA, Regeneron's string of recent troubles with its Eylea franchise is continuing to pull ...

EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...

On an adjusted basis, Regeneron earned $8.22 per share in the first quarter, below the average analyst estimate of $8.82, ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...

The company’s $3 billion in earnings for the first quarter missed on both top and bottom line, according to BMO Capital ...

The May 2025 video game releases look like they may match or exceed all of the previous months of this jam-packed year.

What would we buy if money were no object? Most people have mental lists of extravagant, unnecessary-but-awesome tech they'd ...

Explore BlueLinx Holdings' role in building materials, its growth potential amid interest rate impacts, and competitive edge ...

Alvotech faces challenges with potential tariffs and profitability, despite strong revenue growth and a robust pipeline. See ...

Whether you’re doing Mother’s Day long-distance, or visiting mom at home, your gifts for mom should be anything but homely.

Full-sized pickup trucks average more than $60,000 nowadays, but these pickups offer luxury, fancy features, and high style ...